- Home
- ORI vs QGEN Comparison
ORI vs QGEN Comparison
Compare ORI & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- QGEN
- Stock Information
- Founded
- ORI 1923
- QGEN 1986
- Country
- ORI United States
- QGEN Netherlands
- Employees
- ORI N/A
- QGEN N/A
- Industry
- ORI Property-Casualty Insurers
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORI Finance
- QGEN Health Care
- Exchange
- ORI Nasdaq
- QGEN Nasdaq
- Market Cap
- ORI 9.4B
- QGEN 9.1B
- IPO Year
- ORI N/A
- QGEN 1996
- Fundamental
- Price
- ORI $36.97
- QGEN $48.28
- Analyst Decision
- ORI Buy
- QGEN Buy
- Analyst Count
- ORI 1
- QGEN 8
- Target Price
- ORI $43.00
- QGEN $50.68
- AVG Volume (30 Days)
- ORI 1.5M
- QGEN 1.4M
- Earning Date
- ORI 07-24-2025
- QGEN 08-05-2025
- Dividend Yield
- ORI 3.13%
- QGEN 3.14%
- EPS Growth
- ORI 19.19
- QGEN N/A
- EPS
- ORI 3.04
- QGEN 0.42
- Revenue
- ORI $8,329,500,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- ORI $8.35
- QGEN $6.36
- Revenue Next Year
- ORI $6.23
- QGEN $6.18
- P/E Ratio
- ORI $12.19
- QGEN $114.46
- Revenue Growth
- ORI 10.83
- QGEN 3.31
- 52 Week Low
- ORI $31.36
- QGEN $37.63
- 52 Week High
- ORI $39.84
- QGEN $48.90
- Technical
- Relative Strength Index (RSI)
- ORI 40.81
- QGEN 62.35
- Support Level
- ORI $36.19
- QGEN $47.68
- Resistance Level
- ORI $38.20
- QGEN $48.90
- Average True Range (ATR)
- ORI 0.62
- QGEN 0.80
- MACD
- ORI -0.14
- QGEN -0.11
- Stochastic Oscillator
- ORI 19.29
- QGEN 75.49
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).